Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 553 to 558 of 558 entries
Sorted by: Best Match Show Resources per page
Intrahepatic Cholestasis of Pregnancy.

Geburtshilfe und Frauenheilkunde

Jurk SM, Kremer AE, Schleussner E.
PMID: 34393257
Geburtshilfe Frauenheilkd. 2021 Aug;81(8):940-947. doi: 10.1055/a-1522-5178. Epub 2021 Aug 09.

Intrahepatic cholestasis of pregnancy (ICP) is a rare but potentially serious complication of pregnancy, the main symptom of which is intense pruritus with elevated serum levels of bile acids. The elevated serum bile acid concentration is regarded as a...

Cite
Jurk SM, Kremer AE, Schleussner E. Intrahepatic Cholestasis of Pregnancy. Geburtshilfe Frauenheilkd. 2021;81(8):940-947doi: 10.1055/a-1522-5178.
Jurk, S. M., Kremer, A. E., & Schleussner, E. (2021). Intrahepatic Cholestasis of Pregnancy. Geburtshilfe und Frauenheilkunde, 81(8), 940-947. https://doi.org/10.1055/a-1522-5178
Jurk, Stanisław M, et al. "Intrahepatic Cholestasis of Pregnancy." Geburtshilfe und Frauenheilkunde vol. 81,8 (2021): 940-947. doi: https://doi.org/10.1055/a-1522-5178
Jurk SM, Kremer AE, Schleussner E. Intrahepatic Cholestasis of Pregnancy. Geburtshilfe Frauenheilkd. 2021 Aug;81(8):940-947. doi: 10.1055/a-1522-5178. Epub 2021 Aug 09. PMID: 34393257; PMCID: PMC8354350.
Copy Download .nbib Format: NLM
The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy.

Cureus

Papakonstantinou D, Paspala A, Pikoulis E, Perrea DN, Machairas A, Agrogiannis G, Machairas N, Patapis P, Zavras NJ.
PMID: 34268031
Cureus. 2021 Jun 07;13(6):e15500. doi: 10.7759/cureus.15500. eCollection 2021 Jun.

INTRODUCTION: Hepatic regeneration is a complex process involving a multitude of well-timed molecular operations. Ursodeoxycholic acid (UDCA) is postulated to exert a protective effect against oxidative stress and enzymatic degradation of the extracellular matrix, in turn potentiating the regenerative...

Cite
Papakonstantinou D, Paspala A, Pikoulis E, et al. The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy. Cureus. 2021;13(6):e15500doi: 10.7759/cureus.15500.
Papakonstantinou, D., Paspala, A., Pikoulis, E., Perrea, D. N., Machairas, A., Agrogiannis, G., Machairas, N., Patapis, P., & Zavras, N. J. (2021). The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy. Cureus, 13(6), e15500. https://doi.org/10.7759/cureus.15500
Papakonstantinou, Dimitrios, et al. "The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy." Cureus vol. 13,6 (2021): e15500. doi: https://doi.org/10.7759/cureus.15500
Papakonstantinou D, Paspala A, Pikoulis E, Perrea DN, Machairas A, Agrogiannis G, Machairas N, Patapis P, Zavras NJ. The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy. Cureus. 2021 Jun 07;13(6):e15500. doi: 10.7759/cureus.15500. eCollection 2021 Jun. PMID: 34268031; PMCID: PMC8262578.
Copy Download .nbib Format: NLM
Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.

Journal of hepatology

Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
PMID: 33276032
J Hepatol. 2021 May;74(5):1087-1096. doi: 10.1016/j.jhep.2020.11.038. Epub 2020 Dec 01.

BACKGROUND & AIMS: Intrahepatic cholestasis of pregnancy (ICP) is associated with an increased risk of stillbirth. This study aimed to assess the relationship between bile acid concentrations and fetal cardiac dysfunction in patients with ICP who were or were...

Cite
Vasavan T, Deepak S, Jayawardane IA, et al. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. J Hepatol. 2020;74(5):1087-1096doi: 10.1016/j.jhep.2020.11.038.
Vasavan, T., Deepak, S., Jayawardane, I. A., Lucchini, M., Martin, C., Geenes, V., Yang, J., Lövgren-Sandblom, A., Seed, P. T., Chambers, J., Stone, S., Kurlak, L., Dixon, P. H., Marschall, H. U., Gorelik, J., Chappell, L., Loughna, P., Thornton, J., Pipkin, F. B., Hayes-Gill, B., Fifer, W. P., & Williamson, C. (2021). Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. Journal of hepatology, 74(5), 1087-1096. https://doi.org/10.1016/j.jhep.2020.11.038
Vasavan, Tharni, et al. "Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations." Journal of hepatology vol. 74,5 (2021): 1087-1096. doi: https://doi.org/10.1016/j.jhep.2020.11.038
Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. J Hepatol. 2021 May;74(5):1087-1096. doi: 10.1016/j.jhep.2020.11.038. Epub 2020 Dec 01. PMID: 33276032; PMCID: PMC8062912.
Copy Download .nbib Format: NLM
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis.

Journal of hepatology

Vuppalanchi R, Caldwell SH, Pyrsopoulos N, deLemos AS, Rossi S, Levy C, Goldberg DS, Mena EA, Sheikh A, Ravinuthala R, Shaikh F, Bainbridge JD, Parmar DV, Chalasani NP.
PMID: 34487750
J Hepatol. 2022 Jan;76(1):75-85. doi: 10.1016/j.jhep.2021.08.025. Epub 2021 Sep 04.

BACKGROUND & AIM: Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with dual agonistic properties (α/γ). Due to a strong mechanistic rationale, we aimed to test the safety and efficacy of saroglitazar in patients with primary biliary cholangitis...

Cite
Vuppalanchi R, Caldwell SH, Pyrsopoulos N, et al. Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis. J Hepatol. 2021;76(1):75-85doi: 10.1016/j.jhep.2021.08.025.
Vuppalanchi, R., Caldwell, S. H., Pyrsopoulos, N., deLemos, A. S., Rossi, S., Levy, C., Goldberg, D. S., Mena, E. A., Sheikh, A., Ravinuthala, R., Shaikh, F., Bainbridge, J. D., Parmar, D. V., & Chalasani, N. P. (2022). Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis. Journal of hepatology, 76(1), 75-85. https://doi.org/10.1016/j.jhep.2021.08.025
Vuppalanchi, Raj, et al. "Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis." Journal of hepatology vol. 76,1 (2022): 75-85. doi: https://doi.org/10.1016/j.jhep.2021.08.025
Vuppalanchi R, Caldwell SH, Pyrsopoulos N, deLemos AS, Rossi S, Levy C, Goldberg DS, Mena EA, Sheikh A, Ravinuthala R, Shaikh F, Bainbridge JD, Parmar DV, Chalasani NP. Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis. J Hepatol. 2022 Jan;76(1):75-85. doi: 10.1016/j.jhep.2021.08.025. Epub 2021 Sep 04. PMID: 34487750.
Copy Download .nbib Format: NLM
Outcome of pregnancy in patients with primary sclerosing cholangitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Wronka KM, Bik E, Milkiewicz P.
PMID: 34518127
Dig Liver Dis. 2021 Sep 10; doi: 10.1016/j.dld.2021.08.015. Epub 2021 Sep 10.

BACKGROUND: Data on the clinical course of primary sclerosing cholangitis (PSC) during pregnancy remain scarce. Herein, we assessed the maternal and fetal outcomes of pregnancy in this condition.METHODS: We reviewed 104 consecutive female outpatients with PSC using a structured...

Cite
Wronka KM, Bik E, Milkiewicz P. Outcome of pregnancy in patients with primary sclerosing cholangitis. Dig Liver Dis. 2021;doi: 10.1016/j.dld.2021.08.015.
Wronka, K. M., Bik, E., & Milkiewicz, P. (2021). Outcome of pregnancy in patients with primary sclerosing cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, . https://doi.org/10.1016/j.dld.2021.08.015
Wronka, Karolina M, et al. "Outcome of pregnancy in patients with primary sclerosing cholangitis." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1016/j.dld.2021.08.015
Wronka KM, Bik E, Milkiewicz P. Outcome of pregnancy in patients with primary sclerosing cholangitis. Dig Liver Dis. 2021 Sep 10; doi: 10.1016/j.dld.2021.08.015. Epub 2021 Sep 10. PMID: 34518127.
Copy Download .nbib Format: NLM
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life.

Hepatic medicine : evidence and research

Sivakumar T, Kowdley KV.
PMID: 34483690
Hepat Med. 2021 Aug 28;13:83-92. doi: 10.2147/HMER.S256692. eCollection 2021.

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic cholestatic immune-mediated liver disease characterized by injury to intrahepatic bile ducts that may ultimately progress to cirrhosis and liver failure and result in the need for...

Cite
Sivakumar T, Kowdley KV. Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life. Hepat Med. 2021;13:83-92doi: 10.2147/HMER.S256692.
Sivakumar, T., & Kowdley, K. V. (2021). Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life. Hepatic medicine : evidence and research, 1383-92. https://doi.org/10.2147/HMER.S256692
Sivakumar, Tarika, and Kowdley, Kris V. "Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life." Hepatic medicine : evidence and research vol. 13 (2021): 83-92. doi: https://doi.org/10.2147/HMER.S256692
Sivakumar T, Kowdley KV. Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life. Hepat Med. 2021 Aug 28;13:83-92. doi: 10.2147/HMER.S256692. eCollection 2021. PMID: 34483690; PMCID: PMC8409764.
Copy Download .nbib Format: NLM
Showing 553 to 558 of 558 entries